ES2303275T3 - Compuestos sulfonamido que antagonizan con el receptor vaniloide trpv1. - Google Patents

Compuestos sulfonamido que antagonizan con el receptor vaniloide trpv1. Download PDF

Info

Publication number
ES2303275T3
ES2303275T3 ES05796943T ES05796943T ES2303275T3 ES 2303275 T3 ES2303275 T3 ES 2303275T3 ES 05796943 T ES05796943 T ES 05796943T ES 05796943 T ES05796943 T ES 05796943T ES 2303275 T3 ES2303275 T3 ES 2303275T3
Authority
ES
Spain
Prior art keywords
compounds
benzyl
methoxy
hydroxy
baselineskip
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES05796943T
Other languages
English (en)
Spanish (es)
Inventor
Pier Giovanni Baraldi
Pier Andrea Borea
Pierangelo Geppetti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmeste SRL
Original Assignee
Pharmeste SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmeste SRL filed Critical Pharmeste SRL
Application granted granted Critical
Publication of ES2303275T3 publication Critical patent/ES2303275T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04—Derivatives of thiourea
    • C07C335/16—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C335/18—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
    • C07C311/47—Y being a hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04—Derivatives of thiourea
    • C07C335/06—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to acyclic carbon atoms
    • C07C335/10—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • C07C335/12—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04—Derivatives of thiourea
    • C07C335/16—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ES05796943T 2004-10-26 2005-10-18 Compuestos sulfonamido que antagonizan con el receptor vaniloide trpv1. Expired - Lifetime ES2303275T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT002042A ITMI20042042A1 (it) 2004-10-26 2004-10-26 Derivati solfonammidici antagonisti del recettore dei vanilloidi trpv1
ITMI04A2042 2004-10-26

Publications (1)

Publication Number Publication Date
ES2303275T3 true ES2303275T3 (es) 2008-08-01

Family

ID=35501228

Family Applications (1)

Application Number Title Priority Date Filing Date
ES05796943T Expired - Lifetime ES2303275T3 (es) 2004-10-26 2005-10-18 Compuestos sulfonamido que antagonizan con el receptor vaniloide trpv1.

Country Status (8)

Country Link
US (1) US7579378B2 (enExample)
EP (1) EP1805138B1 (enExample)
JP (1) JP5080260B2 (enExample)
AT (1) ATE389634T1 (enExample)
DE (1) DE602005005512T2 (enExample)
ES (1) ES2303275T3 (enExample)
IT (1) ITMI20042042A1 (enExample)
WO (1) WO2006045498A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006225496A1 (en) * 2005-03-19 2006-09-28 Amorepacific Corporation Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same
WO2009081222A1 (en) 2007-12-21 2009-07-02 Glenmark Pharmaceuticals, S.A. Substituted tricyclic pyridine or pyrimidine vanilloid receptor ligands
CN106146362B (zh) * 2015-04-15 2018-04-03 南京理工大学 一种合成c‑7280948的方法
CN107759477A (zh) * 2017-11-20 2018-03-06 阿里化学(常州)有限公司 一种对硝基苯乙胺盐酸盐的生产制备方法
EP4074317A1 (en) 2021-04-14 2022-10-19 Bayer AG Phosphorus derivatives as novel sos1 inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2154323C (en) * 1994-07-21 2001-03-27 Tomoaki Nagai Aminobenzenesulfonamide derivative and recording medium using the same
AU2001280229B2 (en) 2000-08-21 2006-12-07 Pacific Corporation Novel thiourea derivatives and the pharmaceutical compositions containing the same
JP2004506714A (ja) * 2000-08-21 2004-03-04 パシフィック　コーポレーション 新規チオ尿素化合物及びこれを含有する薬学的組成物
WO2002070467A1 (en) * 2001-02-26 2002-09-12 4Sc Ag Derivatives of diphenylurea, diphenyloxalic acid diamide and diphenylsulfuric acid diamide and their use as medicaments

Also Published As

Publication number Publication date
US20090118374A1 (en) 2009-05-07
ATE389634T1 (de) 2008-04-15
US7579378B2 (en) 2009-08-25
WO2006045498A1 (en) 2006-05-04
DE602005005512D1 (de) 2008-04-30
EP1805138B1 (en) 2008-03-19
ITMI20042042A1 (it) 2005-01-26
EP1805138A1 (en) 2007-07-11
JP5080260B2 (ja) 2012-11-21
JP2008517884A (ja) 2008-05-29
DE602005005512T2 (de) 2009-04-16

Similar Documents

Publication Publication Date Title
JP5650844B2 (ja) 新規化合物
ES2991366T3 (es) Inhibidores de NEK7 cinasa
CA3119526A1 (en) Small molecule degraders of helios and methods of use
PL190866B1 (pl) Inhibitor adhezji komórek, sposób jego wytwarzania i jego zastosowanie oraz kompozycja farmaceutyczna i sposób jej wytwarzania
AU2011290724A1 (en) 2-(arylamino)-3H-imidazo[4,5-b]pyridine-6-carboxamide derivatives and their use as mPGES-1 inhibitors
BRPI0722079B1 (pt) pirimidinas 5,6-substituídas inibidoras de hiv e composição farmacêutica que as compreende
PL191876B1 (pl) Nowe kwasy sulfonyloaminokarboksylowe i sposób ich wytwarzania, środek farmaceutyczny i ich zastosowanie do wytwarzania leku
RS53684B1 (sr) Modulatori prostaciklinskog (pgi2) receptora korisnih u tretmanu poremećaja vezanih za pgi2
CA2694251A1 (en) B1-antagonists
CA3191410A1 (en) Sulphamoyl urea derivatives containing alkyl-oxacycloalkyl moiety and uses thereof
ES2303275T3 (es) Compuestos sulfonamido que antagonizan con el receptor vaniloide trpv1.
ES2213405T3 (es) Omega-amidas de n-arilsulfonil-aminoacidos.
BRPI0608714A2 (pt) compostos, isÈmeros dos mesmos, ou sais farmaceuticamente aceitáveis dos mesmos como antagonista do receptor vanilóide, e composições farmacêuticas contendo os mesmos
RU2529676C2 (ru) Новые (поли)аминоалкиламиноалкиламидные, алкил-мочевинные или алкил-сульфонамидные производные эпиподофиллотоксина, способ их получения и их применение в терапии в качестве противораковых средств
CZ2017772A3 (cs) Způsob přípravy N-[4-(2-{[2-(4-methansulfonamidofenoxy)ethyl](methyl)amino}ethyl)fenyl]methansulfonamidu (Dofetilidu)
WO2020103939A1 (zh) 三唑并环类化合物、其制备方法、中间体和应用
BRPI0613958A2 (pt) composto bicìclico, seu uso como inibidor p38 e composição farmacêutica contendo o mesmo
ES2236971T3 (es) Derivados del indol utiles, entre otras cosas, para el tratamiento de la osteoporosis.
KR20220123223A (ko) 이타코네이트 및 메틸 이타코네이트의 프로드러그
ES2338136T3 (es) Antagonistas de receptor trpv1 vanilloide.
ES2221482T3 (es) Derivados de tiazol.
WO2009058051A1 (ru) Производные 5-зaмeщeнныx индол-3-карбоновой кислоты, обладающие противовирусной активностью, способ их получения и применение
BRPI0720421A2 (pt) Derivados de uréia de dibenzila substituída por o como antagonistas de receptor de trpv1
WO2025104244A1 (en) Methods of preparing urea derivatives
AU2006263657A1 (en) Substituted N-cinnamyl benzamides